AAREY DRUGS & PHARM LTD
Latest filings
- SEBI Depositories Certificate Filing · Compliance
- Allotment of 11.5 lakh shares on warrant conversion · Fund Raising
- 36th AGM: All 3 Resolutions Passed with Near-Unanimous Approval · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
Manufactures bulk drugs and trades in chemical solvents. In FY26, revenue was Rs 472.269 crore with net profit of Rs 3.9676 crore and an EBITDA margin of about 2.8%. The only disclosed segment is "Pharmaceuticals Product," which made up 100% of segment revenue in the YTD period to September 2019 (Rs 129.7595 crore in revenue and Rs 4.2785 crore in EBIT). Raw materials and traded goods dominate the cost base at 95.4% of revenue, employee costs are minimal at 0.2% of revenue, other operating expenses 2.1%, depreciation 0.6% and capex 2.6%. Q4 FY26 alone contributed Rs 18,947 lakhs of revenue and Rs 155.74 lakhs of profit. The business runs on a thin margin between the cost of raw materials/solvents and the sale of finished bulk drugs and solvents.
Scorecard
Measured from the filed financials · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from AAREY DRUGS & PHARM LTD's filed financials and exchange disclosures
What does AAREY DRUGS & PHARM LTD do?
AAREY DRUGS & PHARM LTD is listed on NSE and BSE, trading under the symbol AAREYDRUGS.
Is AAREY DRUGS & PHARM LTD profitable?
Yes. Over the trailing twelve months AAREY DRUGS & PHARM LTD reported a net profit of ₹4.88 Cr on revenue of ₹415 Cr.
Does AAREY DRUGS & PHARM LTD pay a dividend?
Not in the latest reported year — AAREY DRUGS & PHARM LTD's dividend payout for FY26 was nil.
Is AAREY DRUGS & PHARM LTD debt-free?
No. It reported borrowings of ₹50 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹49 Cr after cash. Debt stands at 0.33× equity.
How much does the AAREY DRUGS & PHARM LTD share price move in a day?
On a typical session AAREY DRUGS & PHARM LTD moves 2.00% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track AAREY DRUGS & PHARM LTD's announcements?
Every NSE and BSE filing by AAREY DRUGS & PHARM LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.